You are here
Supportive care, cancer toxicity management, early global care: tomorrow’s issues
Presentation by Dr. Florian Scotté at the TAO Congress on 19/20 November 2015
Dr. Florian Scotté discusses the importance of coordinating curative therapy with supportive and palliative care. Supportive care is essential, as cancer therapy is frequently interrupted or discontinued due to toxicities. This means that improving the efficacy of supportive care will also improve the efficacy of the curative treatment, and it has been shown that therapeutic progress and toxicity management jointly improve survival. Dr. Scotté therefore calls for a multidisciplinary approach which includes all health professionals. He also reviews efficacy and safety data from several trials. Another essential point is patient-centered care, based on patient-reported outcomes as new assessment instrument. Dr. Scotté presents the “NEXT PROCHE” programme, which has been developed by the European Hospital Georges Pompidou. The objective of this programme is to link precision medicine and personalized medicine. It features an application for following up cancer patients, enabling a better coordination between hospitals and other healthcare providers and taking into account the patient’s personal environment.
Dr. Florian Scotté, Hôpital Européen Georges Pompidou, Paris, France